Product Information
DEXTROAMP-AMPHET ER 30 MG CAP is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.5227 per EA under NDC 31722019501. Its NADAC has been published 224 times since Mar 16, 2022.
DEXTROAMP-AMPHET ER 30 MG CAP
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfateStrength
7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722019501
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA214959On Market Since
9/29/2021
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has been published 224 times since Mar 16, 2022, and over the history we have for it it has declined 9.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5227 per EA |
|---|---|
| All-time high | $0.7671 (Nov 13, 2024) |
| All-time low | $0.3360 (May 22, 2024) |
| 52-week high | $0.5944 |
| 52-week low | $0.4621 |
| Median price | $0.5947 |
| Average price | $0.5918 |
| Largest weekly change | +61.4% (Jun 19, 2024) |
| Weeks tracked | 224 |
| Tracking since | Mar 16, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 30 MG CAP, manufactured by Camber Pharmaceuticals Inc., is $0.5227 per EA (NDC 31722019501), effective Jun 24, 2026.
How has the price of DEXTROAMP-AMPHET ER 30 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has declined 9.1%. It has been tracked across 224 weekly CMS publications since Mar 16, 2022.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 30 MG CAP?
Since Mar 16, 2022, the NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has ranged from a low of $0.3360 (May 22, 2024) to a high of $0.7671 (Nov 13, 2024), with a median of $0.5947 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 30 MG CAP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DEXTROAMP-AMPHET ER 30 MG CAP, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHET ER 30 MG CAP?
DEXTROAMP-AMPHET ER 30 MG CAP (NDC 31722019501) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification